Partner & Employee Best Access
First time users must log in to Best Access via the Virtual Environment, not via this link.


May 16, 2016

IPO's patent to Gilead's Sovaldi challenged at Delhi High Court

On May 9, 2016, the Indian Patent Office (IPO) granted a patent to Gilead Pharmasset, LLC (Gilead) for its blockbuster anti Hepatitis-C virus (HCV) drug, sofobuvir (known commercially as "Solvaldi") holding that the invention was novel, inventive and did not fall within the preclusion of Section 3(d) of the Indian Patents Act. The 58 page […]
back to top